Cargando…

Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults

Mucosal healing (MH) is the key therapeutic target of inflammatory bowel disease (IBD). The evaluation of MH remains challenging, with endoscopy being the golden standard. We performed a comprehensive overview of the performance of fecal-, serum-, and urine-based biochemical markers in colonic IBD t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krzystek-Korpacka, Małgorzata, Kempiński, Radosław, Bromke, Mariusz, Neubauer, Katarzyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344443/ https://www.ncbi.nlm.nih.gov/pubmed/32498475 http://dx.doi.org/10.3390/diagnostics10060367

Ejemplares similares

Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis
por: Bromke, Mariusz A., et al.
Publicado: (2021)

Oxidative Stress Markers in Inflammatory Bowel Diseases: Systematic Review
por: Krzystek-Korpacka, Małgorzata, et al.
Publicado: (2020)

Bile Acid Signaling in Inflammatory Bowel Disease
por: Bromke, Mariusz A., et al.
Publicado: (2021)

Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis
por: Matusiewicz, Malgorzata, et al.
Publicado: (2017)

Transcriptional and Metabolomic Analysis of L-Arginine/Nitric Oxide Pathway in Inflammatory Bowel Disease and Its Association with Local Inflammatory and Angiogenic Response: Preliminary Findings
por: Krzystek-Korpacka, Małgorzata, et al.
Publicado: (2020)

Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment
por: Neubauer, Katarzyna, et al.
Publicado: (2019)

Reduced Transferrin Levels in Active Inflammatory Bowel Disease
por: Matusiewicz, Malgorzata, et al.
Publicado: (2017)

Peripheral Lymphocytes of Patients with Inflammatory Bowel Disease Have Altered Concentrations of Key Apoptosis Players: Preliminary Results
por: Neubauer, Katarzyna, et al.
Publicado: (2018)

Matrix Metalloproteinase-9: Its Interplay with Angiogenic Factors in Inflammatory Bowel Diseases
por: Matusiewicz, Malgorzata, et al.
Publicado: (2014)

Ultrasound Elastography in the Assessment of the Intestinal Changes in Inflammatory Bowel Disease—Systematic Review
por: Ślósarz, Dominika, et al.
Publicado: (2021)

Oversecretion and Overexpression of Nicotinamide Phosphoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Activity, Severity of Inflammatory Response and Hypoxia
por: Neubauer, Katarzyna, et al.
Publicado: (2019)

Inflammatory bowel disease induced by bimekizumab
por: Wietrzykowska-Grishanovich, Dominika, et al.
Publicado: (2022)

L-Arginine/NO Pathway Metabolites in Colorectal Cancer: Relevance as Disease Biomarkers and Predictors of Adverse Clinical Outcomes Following Surgery
por: Bednarz-Misa, Iwona, et al.
Publicado: (2020)

L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs
por: Krzystek-Korpacka, Małgorzata, et al.
Publicado: (2020)

Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease
por: Smith, Samuel C. L., et al.
Publicado: (2021)

Diagnostic Potential of Systemic Eosinophil-Associated Cytokines and Growth Factors in IBD
por: Neubauer, Katarzyna, et al.
Publicado: (2018)

Cumulative Effective Dose from Medical Imaging in Inflammatory Bowel Disease
por: Łukawska, Agata, et al.
Publicado: (2021)

Mucosal healing and inflammatory bowel disease: Therapeutic implications and new targets
por: Otte, Megan Lynn, et al.
Publicado: (2023)

HDL Accessory Proteins in Parkinson’s Disease—Focusing on Clusterin (Apolipoprotein J) in Regard to Its Involvement in Pathology and Diagnostics—A Review
por: Berdowska, Izabela, et al.
Publicado: (2022)

Nampt/PBEF/Visfatin Upregulation in Colorectal Tumors, Mirrored in Normal Tissue and Whole Blood of Colorectal Cancer Patients, Is Associated with Metastasis, Hypoxia, IL1β, and Anemia
por: Neubauer, Katarzyna, et al.
Publicado: (2015)

Local and Systemic Interleukin-32 in Esophageal, Gastric, and Colorectal Cancers: Clinical and Diagnostic Significance
por: Diakowska, Dorota, et al.
Publicado: (2020)

Editorial: Immune-Epithelial Crosstalk in Inflammatory Bowel Diseases and Mucosal Wound Healing
por: Leppkes, Moritz, et al.
Publicado: (2018)

Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review
por: State, Monica, et al.
Publicado: (2021)

Monocyte Chemotactic Proteins (MCP) in Colorectal Adenomas Are Differently Expressed at the Transcriptional and Protein Levels: Implications for Colorectal Cancer Prevention
por: Wierzbicki, Jarosław, et al.
Publicado: (2021)

Altered L-Arginine Metabolic Pathways in Gastric Cancer: Potential Therapeutic Targets and Biomarkers
por: Bednarz-Misa, Iwona, et al.
Publicado: (2021)

A pro-inflammatory phenotype is associated with behavioural traits in children with Prader–Willi syndrome
por: Krefft, Maja, et al.
Publicado: (2020)

Correlation of MMP-3 and MMP-9 with Crohn’s Disease Activity in Children
por: Kofla-Dlubacz, Anna, et al.
Publicado: (2011)

Sitagliptin Modulates Oxidative, Nitrative and Halogenative Stress and Inflammatory Response in Rat Model of Hepatic Ischemia-Reperfusion
por: Trocha, Małgorzata, et al.
Publicado: (2021)

Association of sleep quality and mucosal healing in patients with inflammatory bowel disease in clinical remission
por: Michalopoulos, George, et al.
Publicado: (2018)

Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted?
por: Van den Berghe, Nathalie, et al.
Publicado: (2019)

An Improved Score for the Evaluation of Mucosal Healing in Inflammatory Bowel Disease—A Pilot Study
por: Neamți, Lidia, et al.
Publicado: (2023)

A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment
por: Marotti, Valentina, et al.
Publicado: (2023)

Simultaneous LC-MS/MS-Based Quantification of Free 3-Nitro-l-tyrosine, 3-Chloro-l-tyrosine, and 3-Bromo-l-tyrosine in Plasma of Colorectal Cancer Patients during Early Postoperative Period
por: Fleszar, Mariusz G., et al.
Publicado: (2020)

Distinct Local and Systemic Molecular Signatures in the Esophageal and Gastric Cancers: Possible Therapy Targets and Biomarkers for Gastric Cancer
por: Bednarz-Misa, Iwona, et al.
Publicado: (2020)

Tumor location determines midkine level and its association with the disease progression in colorectal cancer patients: a pilot study
por: Krzystek-Korpacka, Malgorzata, et al.
Publicado: (2012)

Elevated systemic interleukin-7 in patients with colorectal cancer and individuals at high risk of cancer: association with lymph node involvement and tumor location in the right colon
por: Krzystek-Korpacka, Malgorzata, et al.
Publicado: (2016)

Reclassifying Pseudopolyps in Inflammatory Bowel Disease: Histologic and Endoscopic Description in the New Era of Mucosal Healing
por: Rezapour, Mona, et al.
Publicado: (2019)

Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
por: Yasutomi, Eriko, et al.
Publicado: (2021)

Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease
por: Wong, Rochelle, et al.
Publicado: (2023)

Local and Systemic IL-7 Concentration in Gastrointestinal-Tract Cancers
por: Bednarz-Misa, Iwona, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a85fv7le543elc3ng0avuin0p9